Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical study.

Author: EngelsmanE, HartG, Schaake-KoningC, van der LindenE H

Paper Details 
Original Abstract of the Article :
Between 1977 and 1980, 118 breast cancer patients with locally advanced disease, T3B-4, any N, M0 or T1-3, tumor positive axillary apex biopsy, were randomized to one of three arms: I: radiotherapy (RT) to the breast and adjacent lymph node areas; II: RT followed by 12 cycles of cyclophosphamide, me...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/0360-3016(85)90028-8

データ提供:米国国立医学図書館(NLM)

Adjuvant Therapy in Locally Advanced Breast Cancer: A Randomized Trial

Breast cancer is a complex and challenging disease, and the search for effective treatments is a continuous journey. This study investigates the role of adjuvant chemo- and hormonal therapy in patients with locally advanced breast cancer. The researchers conducted a randomized clinical trial to compare the effectiveness of three different treatment regimens, including radiotherapy (RT) alone, RT followed by chemotherapy and tamoxifen, and a more intensive chemotherapy regimen with tamoxifen.

Adjuvant Therapy: Limited Impact on Overall Survival

The study found that the addition of adjuvant chemo- and hormonal therapy did not significantly improve overall survival in patients with locally advanced breast cancer. The researchers observed similar survival rates across all three treatment arms, suggesting that RT alone might be sufficient for some patients with this type of breast cancer.

Personalized Treatment for Breast Cancer: A Multifaceted Approach

This research highlights the need for a personalized approach to breast cancer treatment, considering the individual patient's characteristics and disease stage. It's like navigating a complex desert landscape, where the optimal route depends on the specific terrain and resources available. The findings suggest that a multidisciplinary approach, involving careful evaluation of treatment options and considering factors like tumor characteristics and patient preferences, is crucial for achieving optimal outcomes.

Dr.Camel's Conclusion

This study is a reminder that the battle against breast cancer is a multifaceted journey. It emphasizes the importance of individualized treatment plans, considering the specific needs of each patient and the complexity of the disease. The findings encourage a collaborative approach between healthcare professionals and patients to navigate the challenges of breast cancer and achieve the best possible outcomes.

Date :
  1. Date Completed 1985-10-29
  2. Date Revised 2019-07-08
Further Info :

Pubmed ID

3840149

DOI: Digital Object Identifier

10.1016/0360-3016(85)90028-8

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.